← Back to headlines





Revolutionary HIV Drug Lenacapavir Yet to Reach Latin America
Lenacapavir, a groundbreaking HIV drug, has not yet been distributed to Latin American countries like Brazil, Mexico, and Peru, despite their participation in clinical trials, leading to calls for patent reform.
4 Aug, 16:02 — 4 Aug, 16:02
Related Stories

Partners Group Replaces Chief Executive Amid Fund Redemption Pressures
41m ago
TCL Files Lawsuit Against Samsung Over Alleged False Advertising of Mini LED Televisions
43m ago

Trump Advocates Federal Tax Credits to Revitalize U.S. Film Industry
1h ago

Swiss Life Announces 600 Job Cuts Amid Digital Transformation Push
1h ago